These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1680449

  • 1. Experience with subcutaneous erythropoietin in CAPD patients.
    Bailie GR, Plitnick R, Eisele G, Clement C, Rasmussen R.
    Adv Perit Dial; 1991; 7():292-5. PubMed ID: 1680449
    [Abstract] [Full Text] [Related]

  • 2. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M, Bartlett DK, Brier ME, Golper TA.
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [Abstract] [Full Text] [Related]

  • 3. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K, Lubom JA, Collier L, Fleming D, Work J.
    Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
    [Abstract] [Full Text] [Related]

  • 4. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [Abstract] [Full Text] [Related]

  • 5. Once weekly subcutaneous erythropoietin is an effective maintenance therapy in the treatment of anemia of end stage renal disease in patients on CAPD.
    Saleh A, Krane NK, Caballero M, Starks E.
    Adv Perit Dial; 1991 Mar; 7():288-91. PubMed ID: 1680448
    [Abstract] [Full Text] [Related]

  • 6. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G, Bailie GR, Clement C, Wong E.
    Perit Dial Int; 1992 Mar; 12(1):34-6. PubMed ID: 1543777
    [Abstract] [Full Text] [Related]

  • 7. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R, Bloom E, Johnson R, Goldstein M.
    Adv Perit Dial; 1994 Mar; 10():135-8. PubMed ID: 7999811
    [Abstract] [Full Text] [Related]

  • 8. Correction of anemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: a long-term study.
    Cheng IK, Cy C, Chan MK, Yu L, Fang GX, Wei D.
    Clin Nephrol; 1991 May; 35(5):207-12. PubMed ID: 1855328
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R, Bloom E, Johnson R.
    Adv Perit Dial; 1993 May; 9():177-80. PubMed ID: 8105918
    [Abstract] [Full Text] [Related]

  • 10. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
    Ahsan N.
    Adv Perit Dial; 2000 May; 16():80-4. PubMed ID: 11045266
    [Abstract] [Full Text] [Related]

  • 11. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA, Selgas R, Miranda B, Fernandez-Zamorano A, Borrego F, Romero JR, Caparros G, Riñon C, Sanchez Sicilia L.
    Adv Perit Dial; 1991 May; 7():296-300. PubMed ID: 1680450
    [Abstract] [Full Text] [Related]

  • 12. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 1999 May; 15():60-4. PubMed ID: 10682073
    [Abstract] [Full Text] [Related]

  • 13. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM, Gutiérrez MJ, Sánchez G, Kornhauser C.
    Rev Invest Clin; 1996 May; 48(3):173-7. PubMed ID: 8966377
    [Abstract] [Full Text] [Related]

  • 14. Subcutaneous recombinant human erythropoietin in patients on CAPD.
    Lye WC, Lee EJ.
    Adv Perit Dial; 1991 May; 7():285-7. PubMed ID: 1680447
    [Abstract] [Full Text] [Related]

  • 15. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
    Goldraich I, Goldraich N.
    Adv Perit Dial; 1992 May; 8():440-3. PubMed ID: 1361843
    [Abstract] [Full Text] [Related]

  • 16. The use of subcutaneous erythropoietin in CAPD patients.
    Piraino B, Johnston JR.
    Clin Nephrol; 1990 Apr; 33(4):200-2. PubMed ID: 2350907
    [Abstract] [Full Text] [Related]

  • 17. Treatment of the anemia with human recombinant erythropoietin in CAPD patients.
    Miranda B, Selgas R, Riñon C, Fernandez-Zamorano A, Borrego F, Ortuño F, Lopez-Revuelta K, Torre A, Sanchez Sicilia L.
    Adv Perit Dial; 1990 Apr; 6():296-301. PubMed ID: 1982831
    [Abstract] [Full Text] [Related]

  • 18. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR.
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
    Zelichowski G, Lubas A, Sienkiewicz M, Janusz E, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of recombinant erythropoietin after subcutaneous or intraperitoneal administration to patients on CAPD.
    Icardi A, Paoletti E, Molinelli G.
    Adv Perit Dial; 1990 Apr; 6():292-5. PubMed ID: 1982830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.